Clinical trials
Recruiting Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 4 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Enliven Therapeutics | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Crossbow Therapeutics, Inc. | 1 |
| Eilean Therapeutics AU Pty Ltd | 1 |
| Florida International University | 1 |
| Fred Hutchinson Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Marlise Luskin, MD | 1 |
| Mendus | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 16 |
| Leukemia, Myeloid, Acute | 7 |
| Myelodysplastic Syndromes | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Primary Myelofibrosis | 4 |
| Blast Crisis | 3 |
| Burkitt Lymphoma | 2 |
| Hematologic Neoplasms | 2 |
| Leukemia, Myeloid, Chronic-Phase | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.